This annual report and financial statements (“Annual Report”) of Mediclinic International plc (the “Company” or “Mediclinic”) presents the financial results and the economic, social and environmental performance of Mediclinic for the financial year ended 31 March 2019 (the “reporting period”) and reports on the operations of the Company’s subsidiaries in Switzerland, Southern Africa and the United Arab Emirates (“UAE”) (collectively, the “Group”).


This Annual Report contains information that is deemed useful and relevant to stakeholders, with due regard to their expectations through continuous engagement or information that the board of Directors of Mediclinic (the “Board” or the “Board of Directors”) believes may influence stakeholders’ perception or decision-making. The information aims to provide stakeholders with an understanding of the Group’s financial, economic, social and environmental impacts to enable them to evaluate the ability of Mediclinic to create and sustain value.

This Annual Report was prepared in accordance with the International Financial Reporting Standards (“IFRS”), the listing rules of the London Stock Exchange (“LSE”), the listings requirements of the JSE Ltd (“JSE”), the United Kingdom (“UK”) Corporate Governance Code and the UK Companies Act 2006 (including the Companies, Partnerships and Group [Accounts and Non-Financial Reporting] Regulations 2016 aimed at improving the transparency of companies regarding non-financial and diversity information), where relevant. The Company complied with all the provisions of the UK Corporate Governance Code, other than the exceptions explained in the Corporate Governance Statement. The Company’s reporting on sustainable development included in this report (supplemented by the Sustainable Development Report which is available on the Company’s website) was done in accordance with the Global Reporting Initiative Sustainability Reporting Standards 2016 (“GRI Standards”) and the non-financial reporting regulations referred to above.


The Company’s annual financial statements and the Group’s consolidated annual financial statements were audited by the Group’s independent external auditor, PricewaterhouseCoopers LLP (the “external auditor”), in accordance with International Standards of Auditing (UK).

The Group follows various other voluntary external accreditation, certification and assurance initiatives, complementing the Group’s combined assurance model, as reported on in the Risk management section. The Group believes that this adds to the transparency and reliability of information reported to its stakeholders.

* The Group uses adjusted income statement reporting as non-IFRS measures in evaluating performance. Refer to the Financial Review for an explanation and for a reconciliation to the equivalent IFRS measures.